本页面由Tiger Trade Technology Pte. Ltd.提供服务

Neurosense Therapeutics Ltd

0.3763
+0.02597.39%
盘后0.3761-0.0002-0.05%19:30 EDT
成交量:12.85万
成交额:4.73万
市值:1,421.14万
市盈率:-0.86
高:0.3900
开:0.3630
低:0.3512
收:0.3504
52周最高:1.98
52周最低:0.2500
股本:3,776.61万
流通股本:2,584.64万
量比:0.24
换手率:0.50%
股息:- -
股息率:- -
每股收益(TTM):-0.4366
每股收益(LYR):-0.4366
净资产收益率:-2174.98%
总资产收益率:-247.30%
市净率:-9.11
市盈率(LYR):-0.86

数据加载中...

2026/03/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/11/25

SEC问询函

Form CORRESP - Correspondence
2025/08/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/16

SEC问询函

Form CORRESP - Correspondence
2025/01/06

SEC问询函

Form CORRESP - Correspondence
2024/12/13

SEC问询函

Form CORRESP - Correspondence
2024/12/09

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/22

SEC问询函

Form CORRESP - Correspondence
2024/11/19

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/05/21

SEC问询函

Form CORRESP - Correspondence
2024/05/20

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/10

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

SEC问询函

Form CORRESP - Correspondence
2023/09/01

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/31

SEC问询函

Form CORRESP - Correspondence
2023/08/15

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]